Press Releases :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences is a consumer wellness company specializing in nutraceuticals and plant-based foods.

Press Releases

CV Sciences, Inc. Comments on Latest Research Citing Cannabidiol in Reducing the Risk of Post-Traumatic Stress Disorder

Sep 26, 2017

CV Sciences, Inc. Announces Webcast for Investor Update Call

Sep 11, 2017

CV Sciences, Inc. to Host Investor Update Call

Sep 6, 2017

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil(TM), at Natural Products Expo East 2017 in Baltimore, Maryland

Sep 5, 2017

CV Sciences, Inc. to Present at MJAC2017 InvestorsHub International Cannabis Conference

Aug 28, 2017

CV Sciences, Inc. Cites Additional Research to Support Role of Cannabidiol in Overcoming Drug Addictions

Aug 23, 2017

CV Sciences, Inc. Highlights Recent Research Showing Cannabidiol May Reduce Relapses in Smokeless Tobacco Addiction

Aug 15, 2017

CV Sciences, Inc. Announces its Title Sponsorship of the 24th Annual Hemp Industries Association 2017 National Conference

Aug 9, 2017

CV Sciences, Inc. Cites Research Suggesting Possible Therapeutic Role for Cannabidiol in Alzheimer's and Parkinson's Diseases

Aug 1, 2017

CV Sciences, Inc. Hosts Lunch Seminar at National University of Natural Medicine 2017 Medical Cannabis Conference

Jul 25, 2017